Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: TPL Merger

TPL Merger

posted on Apr 04, 2008 06:07AM

If a merger with TPL is out of the question, why include this statement in the options award requirements? Why not just say any JV with TPL not included?

< A successful M & A acquisition brought forth by Mr. Goerner, (a merger or acquisition with TPL excluded)>

Obviously, a merger with TPL is in the realm of possibility. In such a merger, PTSC would need to come up with quite a bit of cash, since IMO TPL has the greater value. I'm speculating about the rush of signings before the close of the quarter. Did they need to raise sufficient PTSC cash for the merger? It would seem that something caused a flurry of signings, which came to an abrupt halt. It is one explanation. Opty


Apr 04, 2008 06:12AM
Share
New Message
Please login to post a reply